The growing focus on post-marketing and observational research has brought a heightened awareness, and scrutiny, on the design and execution of these studies. There are some that feel that only a randomized clinical trial can produce robust study results that are scientifically sound and provide relevant data for sponsors and regulatory authorities. Within this podcast we will explore the scientific integrity of post-marketing and observational research, and how these studies can provide important information that can complement your early phase clinical trial results.
Join PRA in China
The expertise of a global CRO + local know-how to deliver the highest caliber of clinical development services around the world.
Meeting Enrollment Goals Breast Cancer
An open-label, randomized, multi-center study to evaluate the use of Study Drug in the prevention of cancer treatment-related bone loss in…